Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, SH | - |
dc.contributor.author | Kim, KM | - |
dc.contributor.author | Jung, BH | - |
dc.contributor.author | Chung, WY | - |
dc.contributor.author | Park, CS | - |
dc.contributor.author | Chung, BC | - |
dc.date.accessioned | 2024-01-21T09:33:53Z | - |
dc.date.available | 2024-01-21T09:33:53Z | - |
dc.date.created | 2021-09-01 | - |
dc.date.issued | 2003-01-10 | - |
dc.identifier.issn | 0304-3835 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/138911 | - |
dc.description.abstract | To evaluate the potential effect of estrogens in premenopausal female thyroid cancer, the concentrations of 14 estrogens were quantitatively determined in the urine of pre- and post-operative patients with thyroid papillary cancer (18 patients case, 26 similar to 54 years) and normal female subjects (20 cases, 31 similar to 52 years). The highly sensitive gas chromatography-mass spectrometry-selected ion-monitoring method was used for estrogens analysis. And an estrogen-oxidative metabolism and 16alpha-hydroxyestrone to 2-hydroxyestrone (16alpha-OH E1/2-OH El) which is the two primary and competing site of estrogen-oxidation, were determined. Catechol estrogens, including 2-OH E1, were also increased without significant changes of the other estrogen metabolites in pre-operative patients with thyroid papillary cancer compared with normal subjects. The lowest mean value of 16alpha-OH E1/2-OH E1 was remarked in pre-operative patients, and it was significantly different from the ratio of post-operative cases. As a result, it is suggested that the increase of 2-hydroxylation in estrogen metabolism may have a significant association with female thyroid cancer. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved. | - |
dc.language | English | - |
dc.publisher | ELSEVIER SCI IRELAND LTD | - |
dc.subject | BREAST-CANCER | - |
dc.subject | RECEPTORS | - |
dc.subject | ESTRADIOL | - |
dc.subject | WOMEN | - |
dc.title | Estrogens in female thyroid cancer: alteration of urinary profiles in pre- and post-operative cases | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/S0304-3835(02)00514-1 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | CANCER LETTERS, v.189, no.1, pp.27 - 32 | - |
dc.citation.title | CANCER LETTERS | - |
dc.citation.volume | 189 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 27 | - |
dc.citation.endPage | 32 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000179807100004 | - |
dc.identifier.scopusid | 2-s2.0-0037427561 | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalResearchArea | Oncology | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | BREAST-CANCER | - |
dc.subject.keywordPlus | RECEPTORS | - |
dc.subject.keywordPlus | ESTRADIOL | - |
dc.subject.keywordPlus | WOMEN | - |
dc.subject.keywordAuthor | thyroid cancer | - |
dc.subject.keywordAuthor | estrogen profile | - |
dc.subject.keywordAuthor | gas chromatography-mass spectrometry | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.